See tremelimumab in All languages combined, or Wiktionary
Download JSONL data for tremelimumab meaning in English (1.8kB)
{
"etymology_templates": [
{
"args": {
"1": "en",
"2": "-lim-",
"3": "-umab",
"t1": "immunomodulating",
"t2": "human monoclonal antibody"
},
"expansion": "-lim- (“immunomodulating”) + -umab (“human monoclonal antibody”)",
"name": "af"
}
],
"etymology_text": "-lim- (“immunomodulating”) + -umab (“human monoclonal antibody”)",
"head_templates": [
{
"args": {
"1": "-"
},
"expansion": "tremelimumab (uncountable)",
"name": "en-noun"
}
],
"lang": "English",
"lang_code": "en",
"pos": "noun",
"senses": [
{
"categories": [
{
"kind": "other",
"name": "English entries with incorrect language header",
"parents": [
"Entries with incorrect language header",
"Entry maintenance"
],
"source": "w"
},
{
"kind": "other",
"name": "English terms interfixed with -lim-",
"parents": [],
"source": "w"
},
{
"kind": "other",
"name": "English terms suffixed with -umab",
"parents": [],
"source": "w"
},
{
"kind": "topical",
"langcode": "en",
"name": "Pharmaceutical drugs",
"orig": "en:Pharmaceutical drugs",
"parents": [
"Drugs",
"Matter",
"Pharmacology",
"Chemistry",
"Nature",
"Biochemistry",
"Medicine",
"Sciences",
"All topics",
"Biology",
"Fundamental"
],
"source": "w"
}
],
"glosses": [
"A human monoclonal antibody that binds to the protein CTLA-4, used to treat hepatocellular carcinoma."
],
"id": "en-tremelimumab-en-noun-Rz9WwrAO",
"links": [
[
"pharmacology",
"pharmacology"
],
[
"human",
"human"
],
[
"monoclonal antibody",
"monoclonal antibody"
],
[
"protein",
"protein"
],
[
"hepatocellular",
"hepatocellular"
],
[
"carcinoma",
"carcinoma"
]
],
"raw_glosses": [
"(pharmacology) A human monoclonal antibody that binds to the protein CTLA-4, used to treat hepatocellular carcinoma."
],
"synonyms": [
{
"tags": [
"obsolete"
],
"word": "ticilimumab"
}
],
"tags": [
"uncountable"
],
"topics": [
"medicine",
"pharmacology",
"sciences"
],
"wikipedia": [
"tremelimumab"
]
}
],
"word": "tremelimumab"
}
{
"etymology_templates": [
{
"args": {
"1": "en",
"2": "-lim-",
"3": "-umab",
"t1": "immunomodulating",
"t2": "human monoclonal antibody"
},
"expansion": "-lim- (“immunomodulating”) + -umab (“human monoclonal antibody”)",
"name": "af"
}
],
"etymology_text": "-lim- (“immunomodulating”) + -umab (“human monoclonal antibody”)",
"head_templates": [
{
"args": {
"1": "-"
},
"expansion": "tremelimumab (uncountable)",
"name": "en-noun"
}
],
"lang": "English",
"lang_code": "en",
"pos": "noun",
"senses": [
{
"categories": [
"English entries with incorrect language header",
"English lemmas",
"English nouns",
"English terms interfixed with -lim-",
"English terms suffixed with -umab",
"English uncountable nouns",
"en:Pharmaceutical drugs"
],
"glosses": [
"A human monoclonal antibody that binds to the protein CTLA-4, used to treat hepatocellular carcinoma."
],
"links": [
[
"pharmacology",
"pharmacology"
],
[
"human",
"human"
],
[
"monoclonal antibody",
"monoclonal antibody"
],
[
"protein",
"protein"
],
[
"hepatocellular",
"hepatocellular"
],
[
"carcinoma",
"carcinoma"
]
],
"raw_glosses": [
"(pharmacology) A human monoclonal antibody that binds to the protein CTLA-4, used to treat hepatocellular carcinoma."
],
"tags": [
"uncountable"
],
"topics": [
"medicine",
"pharmacology",
"sciences"
],
"wikipedia": [
"tremelimumab"
]
}
],
"synonyms": [
{
"tags": [
"obsolete"
],
"word": "ticilimumab"
}
],
"word": "tremelimumab"
}
This page is a part of the kaikki.org machine-readable English dictionary. This dictionary is based on structured data extracted on 2024-06-29 from the enwiktionary dump dated 2024-06-20 using wiktextract (d4b8e84 and b863ecc). The data shown on this site has been post-processed and various details (e.g., extra categories) removed, some information disambiguated, and additional data merged from other sources. See the raw data download page for the unprocessed wiktextract data.
If you use this data in academic research, please cite Tatu Ylonen: Wiktextract: Wiktionary as Machine-Readable Structured Data, Proceedings of the 13th Conference on Language Resources and Evaluation (LREC), pp. 1317-1325, Marseille, 20-25 June 2022. Linking to the relevant page(s) under https://kaikki.org would also be greatly appreciated.